Xeris Biopharma Holdings, Inc. (XERS)
5.94
-0.08
(-1.33%)
USD |
NASDAQ |
Mar 03, 16:00
5.945
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Free Cash Flow : 9.975M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 141.78M |
| IDEXX Laboratories, Inc. | 1.040B |
| Harrow, Inc. | -20.62M |
| Vir Biotechnology, Inc. | -396.61M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 18.43M |
| Cash from Investing (Quarterly) | -0.071M |
| Cash from Financing (Quarterly) | 13.85M |
| Free Cash Flow Per Share (Quarterly) | 0.1034 |
| Free Cash Flow to Equity (Quarterly) | 17.93M |
| Free Cash Flow to Firm (Quarterly) | 25.63M |
| Free Cash Flow Yield | 1.05% |